Progentior Cell Therapy

From Bench to Market: Advancing the Field of Cellular Therapy

Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:

  • Contract Manufacturing
  • Product & Process Development
  • Consulting
  • GTP Services
  • National Distribution
Photo of a newspaper with a pencil
 

• 08/25/06
Progenitor Cell Therapy to Host Seminar at 6th Annual Somatic Cell Therapy Symposium

Progenitor Cell Therapy invites you to attend “Integrated Solutions for Accelerated Development of Cellular Therapies”, a breakfast seminar hosted by Progenitor Cell Therapy in conjunction with BD Biosciences, Invitrogen, and Wave Biotech.

Date: Tuesday, September 26
Time: 7:30 am – 8:30 am
Location: Hyatt Regency, Bethesda, MD
Room: Judiciary Suite

This seminar is provided complimentary to all registered delegates of the 6th Annual Somatic Cell Therapy Symposium (hosted by ISCT and co-sponsored by FDA & AABB).

Providing technical insight and case histories, this seminar series will focus on some of the leading technologies that can be applied to the manufacture and characterization of cellular therapies in order to accelerate the product development cycle.

Key topics to be addressed will include strategies and tools for the:

  • Selective depletion or enrichment of target cell populations
  • Activation of target cell populations
  • Culture expansion of target cell populations
  • Development of potency assays for cellular therapies
  • Quality control testing of cellular therapies
  • Biological characterization of cellular therapies


The seminar participant will better understand:

  • Cutting edge technologies available for cell separation, cell expansion and cell characterization
  • Strategies to integrate and apply available tools and technology to:
    • Optimize manufacturing processes early in the product development cycle
    • Provide a seamless path to scale-up manufacturing from Phase I clinical trials through commercialization
    • Simplify the regulatory pathway

Faculty

Chair:
Robert A. Preti, PhD, President and Chief Scientific Officer, Progenitor Cell Therapy LLC

Speakers/Panelists:
Stewart Craig, PhD, Vice-President and Chief Technical Officer, Progenitor Cell Therapy LLC
Amitabh Gaur, Ph.D., Director, Custom Technology Team, BD Biosciences
Øystein Åmellem, PhD, Segment Director, Dynal Bead Based Separations, Invitrogen Corporations
Daniella Kranjac, Ch.Eng., Vice President, Sales & Marketing, Wave Biotech